Navigation Links
Fosun Pharma Acquires $14 Million of Chindex Stock
Date:8/27/2010

ent ownership of Chindex to 3,157,163 shares, representing 19.9% of all outstanding shares of Chindex common stock of all classes. A second transaction for 1,057,425 shares, when aggregated with other Chindex shares owned by Fosun Pharma, would gain Fosun Pharma up to 4,214,588 shares, representing approximately a 25% ownership stake in Chindex, is subject to the consummation of the Joint Venture as well as certain other closing conditions. In connection with the purchases and the Joint Venture, Fosun Pharma has agreed to certain voting and standstill limitations and certain other stockholder limitations. Today's stock sale and the proposed final closing are expected to raise an aggregate of approximately $30.0 million, the net proceeds of which are expected to be used, among other things, to continue expansion of the Company's United Family Healthcare network.

Roberta Lipson, President and CEO of Chindex said, "We are pleased to see our arrangements with Fosun progressing as planned and announced. We welcome their participation and expertise as one of our major shareholders. Their credibility and presence in China is an asset to us as we execute our plan to build the leading network of premium care hospitals and clinics across the country. We continue to work towards the consummation of our previously- announced joint venture with Fosun Pharma in medical device manufacture and distribution. Fosun Pharma already operates in this area, and the addition of our medical products division is a great fit which should drive scale and a deeper presence across China."

Chen Qiyu, Chairman of Fosun Pharma said, "We are happy to be increasing our investment in Chindex. Fosun Pharma and Chindex are combining our strengths in healthcare and look forward to growing together in the future. We believe the demand for premium healthcare services which is served by Chindex's United Family Healthcare will continue to accelerate as China's ec
'/>"/>

SOURCE Chindex International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
2. China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
3. Vanda Pharmaceuticals Initiates Phase III Clinical Study Aimed at Resetting the Body Clock
4. Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients
5. Lotus Pharmaceuticals Enter R-Bambuterol(R) Clinical Trial I
6. NCPA: AARP Report Finds Brand Name Drug Prices Soar as Large Pharmacy Benefit Managers Reap Windfall Profits
7. Baxa Corporation Recognized for Pharmacy Automation Leadership and Business Growth
8. Jiangbo Pharmaceuticals Chairman to Ring NASDAQ Opening Bell on August 27, 2010
9. Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
10. Pharmacovigilance Breakthrough: Henry Ford Health System Partners with Rexam and Med Time Technology to Remind Patients to Take Prescription Medication "As Prescribed" to reduce $300 Billion National Healthcare Problem
11. Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Mai 2013 Kepner-Tregoe (KT), das ... heute bekannt, dass der Veteran von 13 ... zum Hauptgeschäftsführer ernannt wurde. Geraghty,s Erfahrung umfasst ... er zahlreiche Führungspositionen bei Fertigungsunternehmen innehielt. Er ... der als Kepner-Tregoe Hauptgeschäftsführer gedient hat, in ...
(Date:5/22/2013)... , May 22, 2013   Upsher-Smith ... completion of its global Phase III clinical ... developed program for the management of epilepsy ... technology.  USL255 is specifically engineered to provide ... topiramate blood levels observed with currently available ...
(Date:5/22/2013)... VIEJO, Calif. , May 22, 2013  Avanir Pharmaceuticals, ... management will present an overview of the company at the ... Care Conference , Presentation date: Wednesday May 29, 2013 ... , Jefferies 2013 Global Healthcare Conference , Presentation date: ... E.T. A live webcast ...
Breaking Medicine Technology:Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2
... Advanced Life Sciences Holdings, Inc. (OTC Bulletin ... oral antibiotic, today announced that it has submitted a final ... Phase III clinical program of Restanza in the treatment of ... been engaged in the SPA process with the FDA over ...
... Novo Nordisk, a world leader in diabetes care, and Indy ... the availability of a wide array of resources to help kids ... who has type 1 diabetes, will hand out one of these ... for Life Conference in Orlando this week – ...
Cached Medicine Technology:Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia 2Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia 3Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia 4Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia 5Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp 2Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp 3Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp 4Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp 5Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp 6
(Date:5/22/2013)... May 22, 2013 Zensah® Compression Apparel ... News article titled "Breast pain while running ... bras could help." According to the article, a ... a substantial amount suffer from breast pain while running ... correct the issue. , Zensah emphasizes the importance ...
(Date:5/22/2013)... 2013 People in the United States have ... water shortages. In much of the world, water shortages are ... Sharon Kleyne. She warns against taking water for granted and ... available so easily in the United States. , Sharon Kleyne ... radio show, heard live or by podcast on World Talk ...
(Date:5/22/2013)... IA (PRWEB) May 22, 2013 Diversity ... piece Handicap This! The performance promotes awareness that ... dreams. The Handicap This! performance will be held Friday, ... High School auditorium. Tickets for Handicap This! can ... This! helps audiences measure the level to which their ...
(Date:5/22/2013)... ARBORA University of Michigan study challenges previous research ... Baseball. , The study, a collaboration between researchers ... Florida, looks deeper into the controversial argument over ... strikes for pitchers of the same race. It ... said Jason Winfree, associate professor of sport management ...
(Date:5/22/2013)... that hospitals may be reaping enormous income for ... bloodstream infections contracted in their intensive care units. ... in the American Journal of Medical Quality ... who develops an avoidable central line-associated bloodstream infection ... for than a similar infection-free patient. Moreover, hospitals ...
Breaking Medicine News(10 mins):Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4
... Light, or photodynamic, therapy can help preserve the ... stage laryngeal (voice box) cancer, according to a study ... is an effective treatment for early laryngeal squamous cell ... side effects than other therapies, while preserving the voice," ...
... HealthDay Reporter , FRIDAY, Jan. 28 (HealthDay News) -- ... pain exacerbated by lack of control -- with doctors poking ... grows near. Hospice care, however, can give back some ... treating pain and helping both the dying person and the ...
... researchers have come one step closer to understanding how ... many common drugs, including some antibiotics, antihistamines and anti-psychotics, ... is estimated around 40-50% of all drugs in development ... electricity in the heart and, as a result, can ...
... Reporter , FRIDAY, Jan. 28 (HealthDay News) -- Vailia Dennis says ... on anyone else,s timetable. Dennis, 91, of Rancho Bernardo, Calif., ... diagnosed with a fatal heart condition. At the time, she was ... heart condition that I have, is one that should have and ...
... News) -- Celiac disease and Crohn,s disease share several genetic ... makes it hard to absorb nutrients properly, is an inherited ... is damaged by gluten and other protein found in wheat ... inflammatory bowel disease. An international team of researchers conducted ...
... Morris Goodman Cancer Research Centre (GCRC), the Research Institute ... DanaFarber Cancer Institute and Harvard Medical School have discovered ... cancer patients are at risk of relapse, thereby sparing ... unnecessary treatment. For years, clinicians have been ...
Cached Medicine News:Health News:Voice-saver: Light therapy for early-stage laryngeal cancer 2Health News:Voice-saver: Light therapy for early-stage laryngeal cancer 3Health News:More People Choosing Hospice at Life's End 2Health News:More People Choosing Hospice at Life's End 3Health News:Victor Chang scientists unlock the 'gates' on sudden cardiac death 2Health News:Woman's Life Refutes a Hospice Myth 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... The Featured Products are ... Mediflex and are offered ... in regular or extra ... equipped with insulation, flush ...
Medicine Products: